Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data.  Visit Dangerousdecibels.org to learn how to protect your hearing. Discover “How loud is too loud?”

Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data. Visit <a href="http://dangerousdecibels.org/" rel="nofollow" target="_blank">Dangerousdecibels.org</a> to learn how to protect your hearing. Discover <a href="http://dangerousdecibels.org/education/information-center/decibel-exposure-time-guidelines/" rel="nofollow" target="_blank">“How loud is too loud?”</a>

Beyond the Data: Hearing Health Across the Lifespan


In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe speaks with Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at the Mayo Clinic. The two expand on Dr. Pritt's lecture focusing on advances in diagnosing tickborne diseases.

In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe speaks with Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at the Mayo Clinic. The two expand on Dr. Pritt's lecture focusing on advances in diagnosing tickborne diseases.

Beyond the Data: Emerging Tickborne Diseases


In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe and Dr. Larry Garber expand on the reasons for medication non-adherence by patients, and priority considerations for helping reduce this risk. 

In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe and Dr. Larry Garber expand on the reasons for medication non-adherence by patients, and priority considerations for helping reduce this risk.

Beyond the Data: Overcoming Barriers to Medication Adherence for Chronic Diseases


Laboratory safety may sound straightforward, but in reality it is supported by complex and ever-changing science. Safety standards and practices evolve as scientists learn more about the materials they handle regularly. In this session of Public Health Grand Rounds from the CDC, presenters will discuss how standards of laboratory safety have improved over the years, what we’ve learned from past incidents, and how establishing safety protocols and training systems can lead to an overall culture of workplace safety, resulting in continued public trust in our science and recommendations. For more details on this Grand Rounds session and its participants, click here.

Laboratory safety may sound straightforward, but in reality it is supported by complex and ever-changing science. Safety standards and practices evolve as scientists learn more about the materials they handle regularly. In this session of Public Health Grand Rounds from the CDC, presenters will discuss how standards of laboratory safety have improved over the years, what we’ve learned from past incidents, and how establishing safety protocols and training systems can lead to an overall culture of workplace safety, resulting in continued public trust in our science and recommendations. For more details on this Grand Rounds session and its participants, <a href="http://www.cdc.gov/cdcgrandrounds/archives/2015/december2015.htm" rel="nofollow" target="_blank">click here</a>.

Strengthening a Culture of Laboratory Safety


CDC's Dr. Phoebe Thorpe speaks with Dr. Sherif Zaki about the important work being done to further reduce the risk of unusual transplant-associated infections. Ensuring that organs are safe requires:  Involvement by many disciplines including: pathologists, epidemiologists, clinicians, and others Global collaboration between federal and state agencies as well as academic institutions Continued focus on improving regulations and screening procedures 

CDC's Dr. Phoebe Thorpe speaks with Dr. Sherif Zaki about the important work being done to further reduce the risk of unusual transplant-associated infections. Ensuring that organs are safe requires: <ul> <li>Involvement by many disciplines including: pathologists, epidemiologists, clinicians, and others</li> <li>Global collaboration between federal and state agencies as well as academic institutions</li> <li>Continued focus on improving regulations and screening procedures</li> </ul>

Beyond the Data: Unusual Transplant-Associated Infections -- Just How Unusual?


CDC's Dr. John Iskander and Dr. Janet Wright discuss the progress that has been made with Million Hearts®, along with the work that is still needed to reach the goal of preventing one million heart attacks and strokes by 2017. Providers should:  Utilize electronic health records to proactively reach individuals with elevated blood pressure or cholesterol Place emphasis on detecting cases of uncontrolled high blood pressure which are hiding in plain sight  Communities can:  Implement smoke-free policies to lower exposure to smoke Adopt food procurement policies that make healthier foods more readily available Encourage and train individuals to self-monitor their blood pressure 

CDC's Dr. John Iskander and Dr. Janet Wright discuss the progress that has been made with Million Hearts®, along with the work that is still needed to reach the goal of preventing one million heart attacks and strokes by 2017. Providers should: <ul> <li>Utilize electronic health records to proactively reach individuals with elevated blood pressure or cholesterol</li> <li>Place emphasis on detecting cases of uncontrolled high blood pressure which are hiding in plain sight</li> </ul> Communities can: <ul> <li>Implement smoke-free policies to lower exposure to smoke</li> <li>Adopt food procurement policies that make healthier foods more readily available</li> <li>Encourage and train individuals to self-monitor their blood pressure</li> </ul>

Beyond the Data: Preventing A Million Heart Attacks and Strokes


CDC's Dr. Phoebe Thorpe and Dr. David Lakey discuss the many costs of preterm birth, and how we can make prevention a priority in the United States. Tune in to find out how some states, like Texas, are educating the public and taking steps to reduce the rates of preterm birth and infant mortality.

CDC's Dr. Phoebe Thorpe and Dr. David Lakey discuss the many costs of preterm birth, and how we can make prevention a priority in the United States. Tune in to find out how some states, like Texas, are educating the public and taking steps to reduce the rates of preterm birth and infant mortality.

Beyond the Data: Public Health Strategies to Prevent Preterm Birth


Dr. John Iskander and Dr. George Luber revisit their discussion on climate change and its impact on human health to update some of the important new scientific findings that have taken place. Since the first session on climate change:  2014 has been confirmed as the hottest year on record, Extreme climate events are occurring more frequently, and Communities are facing heightened health risks due to drought. 

Dr. John Iskander and Dr. George Luber revisit their discussion on climate change and its impact on human health to update some of the important new scientific findings that have taken place. Since the first session on climate change: <ul> <li>2014 has been confirmed as the hottest year on record,</li> <li>Extreme climate events are occurring more frequently, and</li> <li>Communities are facing heightened health risks due to drought.</li> </ul>

Beyond the Data: Climate Change and Health – From Science to Practice


Global health security is the protection of the health of people and societies worldwide. With diseases a plane ride or border crossing away, the importance of global health security has never been clearer. Patterns of global travel and trade pose greater opportunities for infectious diseases to emerge and spread nearly anywhere within 24 hours. The Ebola epidemic in West Africa, which has infected more than 28,000 people across 10 countries and has caused more than 11,200 deaths, highlights the importance of ensuring that every country is prepared to prevent, detect, and respond to outbreaks and emerging health threats.  In this session of Public Health Grand Rounds from the CDC, experts discuss how CDC, other U.S. government agencies, and global partners are working to promote global health security as an international priority and accelerate progress toward a world safe and secure from epidemics of infectious disease. For more details on this Grand Rounds session and its participants, click here. 

Global health security is the protection of the health of people and societies worldwide. With diseases a plane ride or border crossing away, the importance of global health security has never been clearer. Patterns of global travel and trade pose greater opportunities for infectious diseases to emerge and spread nearly anywhere within 24 hours. The Ebola epidemic in West Africa, which has infected more than 28,000 people across 10 countries and has caused more than 11,200 deaths, highlights the importance of ensuring that every country is prepared to prevent, detect, and respond to outbreaks and emerging health threats. In this session of Public Health Grand Rounds from the CDC, experts discuss how CDC, other U.S. government agencies, and global partners are working to promote global health security as an international priority and accelerate progress toward a world safe and secure from epidemics of infectious disease. For more details on this Grand Rounds session and its participants, <a href="http://www.cdc.gov/cdcgrandrounds/archives/2015/september292015.htm" rel="nofollow" target="_blank">click here</a>.

Shifts in Global Health Security: Lessons from Ebola


Host: Matt Birnholz, MD  Twenty-five years ago CDC played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCV still remains a serious threat, both domestically and abroad. HCV remains the most common chronic blood borne infection in the United States, affecting approximately 3.9 million individuals. However up to 50% of HCV-infected persons are unaware of their infection. Globally, there are 180 million people who are chronically infected with the virus, and 3-4 million new infections occur every year. Recent therapeutic advances hold the potential to halt the progression of HCV infection and disease. While HCV-infected persons can be effectively treated, more effort is needed to screen, diagnosis, treat and provide continuity of care. This session of Public Health Grand Rounds will discuss how new screening guidelines, testing methods and therapeutic advances will provide us with an opportunity to improve individual outcomes and to eventually eliminate HCV infection. To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/  …

Host: Matt Birnholz, MD Twenty-five years ago CDC played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCV still remains a serious threat, both domestically and abroad. HCV remains the most common chronic blood borne infection in the United States, affecting approximately 3.9 million individuals. However up to 50% of HCV-infected persons are unaware of their infection. Globally, there are 180 million people who are chronically infected with the virus, and 3-4 million new infections occur every year. Recent therapeutic advances hold the potential to halt the progression of HCV infection and disease. While HCV-infected persons can be effectively treated, more effort is needed to screen, diagnosis, treat and provide continuity of care. This session of Public Health Grand Rounds will discuss how new screening guidelines, testing methods and therapeutic advances will provide us with an opportunity to improve individual outcomes and to eventually eliminate HCV infection. To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit <a href="http://www.cdc.gov/about/grand-rounds/" rel="nofollow" target="_blank">http://www.cdc.gov/about/grand-rounds/</a> …

The 25th Anniversary of the Discovery of the Hepatitis C Virus: Looking Back to Look Forward


Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from top academic centers across the country.

Grand Rounds Nation®

Host: Matt Birnholz, MD  The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined. For health professionals, policymakers and legislators, addressing this problem is complicated. While they push for education, prevention, and enforcement to reverse this epidemic, they must also ensure that patients with a legitimate need for these medications still have access to them. This important session of the CDC's Public Health Grand Rounds addressed these challenges and explored the innovative state and federal policies and interventions that are showing promise in reducing injury and death from this epidemic. This is Part 3 of a 45-minute lecture in three parts. Part 1 &gt;&gt; Part 2 &gt;&gt; To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/. And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline. CDC's participation in the activity is not meant to serve as …

Host: Matt Birnholz, MD The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined. For health professionals, policymakers and legislators, addressing this problem is complicated. While they push for education, prevention, and enforcement to reverse this epidemic, they must also ensure that patients with a legitimate need for these medications still have access to them. This important session of the CDC's Public Health Grand Rounds addressed these challenges and explored the innovative state and federal policies and interventions that are showing promise in reducing injury and death from this epidemic. This is Part 3 of a 45-minute lecture in three parts. <a href="https://reachmd.com/programs/grand-rounds-nation/cdc-prescription-drug-overdoses-an-american-epidemic-part-1/6319/" rel="nofollow" target="_blank">Part 1 &gt;&gt; </a> <a href="https://reachmd.com/programs/grand-rounds-nation/cdc-prescription-drug-overdoses-an-american-epidemic-part-2/6320/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit <a href="http://www.cdc.gov/about/grand-rounds/" rel="nofollow" target="_blank">http://www.cdc.gov/about/grand-rounds/</a>. And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at <a href="http://www2a.cdc.gov/TCEOnline" rel="nofollow" target="_blank">http://www2a.cdc.gov/TCEOnline</a>. CDC's participation in the activity is not meant to serve as …

CDC - Prescription Drug Overdoses: An American Epidemic, Part 3


Host: Matt Birnholz, MD  Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 1 of a lecture in three parts. Part 2 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 1 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-2/6447/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-3/6448/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Approaches in Congestive Heart Failure, Part 1


Host: Matt Birnholz, MD  Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management. Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center. This is Part 2 of a lecture in three parts. Part 1 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management. Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center. This is Part 2 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-respiratory-management-of-children-with-neuromuscular-diseases-part-1/6362/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-respiratory-management-of-children-with-neuromuscular-diseases-part-3/6364/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">their website</a>.

University of Arizona - Respiratory Management of Children with Neuromuscular Diseases, Part 2


Host: Matt Birnholz, MD  The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination. This is Part 1 of a lecture in three parts. Part 2 &gt;&gt; Part …

Host: Matt Birnholz, MD The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination. This is Part 1 of a lecture in three parts. <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-2/6391/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-3/6392/" rel="nofollow" target="_blank">Part …</a>

CDC - TB & HIV: A Deadly Duo, Part 1


Host: Matt Birnholz, MD  The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 3 of a lecture in three …

Host: Matt Birnholz, MD The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 3 of a lecture in three …

CDC - Sodium Reduction: Time for Choice, Part 3


Host: Matt Birnholz, MD  Beyond the inherent moral implications, child abuse is a crime, a tragedy, and a significant public health burden. In the United States, approximately 1 in 5 children have experienced some form of maltreatment, including physical and sexual abuse and the often overlooked danger of neglect. Child maltreatment results in over 1,700 deaths each year; however, the negative health effects reach well beyond these fatalities. In addition to physical injuries, maltreatment causes stress that can disrupt brain development. Thus, children who are maltreated are at higher risk for adult health problems such as alcoholism, smoking, depression, drug abuse, obesity, high-risk sexual behaviors, suicide, and certain chronic diseases. This session of Public Health Grand Rounds from the CDC focused on the epidemiology and costs of child maltreatment, the need for partnerships, and the potential for policy interventions to combat this urgent public health issue. This is Part 2 of a lecture in three parts. Part 1 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/ And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline CDC's …

Host: Matt Birnholz, MD Beyond the inherent moral implications, child abuse is a crime, a tragedy, and a significant public health burden. In the United States, approximately 1 in 5 children have experienced some form of maltreatment, including physical and sexual abuse and the often overlooked danger of neglect. Child maltreatment results in over 1,700 deaths each year; however, the negative health effects reach well beyond these fatalities. In addition to physical injuries, maltreatment causes stress that can disrupt brain development. Thus, children who are maltreated are at higher risk for adult health problems such as alcoholism, smoking, depression, drug abuse, obesity, high-risk sexual behaviors, suicide, and certain chronic diseases. This session of Public Health Grand Rounds from the CDC focused on the epidemiology and costs of child maltreatment, the need for partnerships, and the potential for policy interventions to combat this urgent public health issue. This is Part 2 of a lecture in three parts. <a href="/programs/grand-rounds-nation/cdc-creating-a-healthier-future-through-prevention-of-child-maltreatment-part-1/6501/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/cdc-creating-a-healthier-future-through-prevention-of-child-maltreatment-part-3/6503/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit <a href="http://www.cdc.gov/about/grand-rounds/" rel="nofollow" target="_blank">http://www.cdc.gov/about/grand-rounds/</a> And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at <a href="http://www2a.cdc.gov/TCEOnline" rel="nofollow" target="_blank">http://www2a.cdc.gov/TCEOnline</a> CDC's …

CDC - Creating a Healthier Future through Prevention of Child Maltreatment, Part 2


Host: Matt Birnholz, MD  The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds from the CDC explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 1 of a …

Host: Matt Birnholz, MD The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds from the CDC explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 1 of a …

CDC - Sodium Reduction: Time for Choice, Part 1


Host: Matt Birnholz, MD  This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 2 of a lecture in two parts. Part 1 &gt;&gt;

Host: Matt Birnholz, MD This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated. This is Part 2 of a lecture in two parts. <a href="/programs/grand-rounds-nation/acofp-alternative-approaches-to-the-treatment-of-depression-part-1/6645/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a>

Alternative Approaches to the Treatment of Depression, Part 2


Host: Matt Birnholz, MD  Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy. Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control. This is Part 1 of a lecture in three parts.

Host: Matt Birnholz, MD Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy. Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control. This is Part 1 of a lecture in three parts.

CDC - Lyme Disease: Challenges and Innovations, Part 1


Host: Matt Birnholz, MD  Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 2 of a lecture in three parts. Part 1 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 2 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-1/6446/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-3/6448/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Approaches in Congestive Heart Failure, Part 2


Host: Matt Birnholz, MD  For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 3 of a lecture in three parts. Part 1 &gt;&gt; Part 2 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 3 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-1/6406/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-2/6407/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3


Host: Matt Birnholz, MD  The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 2 of a lecture in three …

Host: Matt Birnholz, MD The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually. Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out! This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden. This is Part 2 of a lecture in three …

CDC - Sodium Reduction: Time for Choice, Part 2


Host: Matt Birnholz, MD  Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy. Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control. This is Part 3 of a lecture in three parts.

Host: Matt Birnholz, MD Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy. Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control. This is Part 3 of a lecture in three parts.

CDC - Lyme Disease: Challenges and Innovations, Part 3


Host: Matt Birnholz, MD  Presenting this session of Grand Rounds is Dr. Leslie Boyer, founding director of the VIPER Institute in the College of Medicine at the University of Arizona. This is Part 1 of a lecture in three parts. Part 2 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Presenting this session of Grand Rounds is Dr. Leslie Boyer, founding director of the VIPER Institute in the College of Medicine at the University of Arizona. This is Part 1 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-global-pediatrics-treatment-of-scorpion-envenomation-part-2/6496/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-global-pediatrics-treatment-of-scorpion-envenomation-part-3/6497/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Global Pediatrics: Treatment of Scorpion Envenomation, Part 1


Host: Matt Birnholz, MD  Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management. Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center. This is Part 3 of a lecture in three parts. Part 1 &gt;&gt; Part 2 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management. Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center. This is Part 3 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-respiratory-management-of-children-with-neuromuscular-diseases-part-1/6362/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-respiratory-management-of-children-with-neuromuscular-diseases-part-2/6363/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">their website</a>.

University of Arizona - Respiratory Management of Children with Neuromuscular Diseases, Part 3


Host: Matt Birnholz, MD  Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 3 of a lecture in three parts. Part 1 &gt;&gt; Part 2 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona. This is Part 3 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-1/6446/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-approaches-in-congestive-heart-failure-part-3/6448/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Approaches in Congestive Heart Failure, Part 3


Host: Matt Birnholz, MD  The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination. This is Part 3 of a lecture in three parts. Part 1 &gt;&gt; Part …

Host: Matt Birnholz, MD The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination. This is Part 3 of a lecture in three parts. <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-1/6390/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-2/6391/" rel="nofollow" target="_blank">Part …</a>

CDC - TB & HIV: A Deadly Duo, Part 3


Host: Matt Birnholz, MD  For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 2 of a lecture in three parts. Part 1 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 2 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-1/6406/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-3/6408/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2


Host: Matt Birnholz, MD  The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. But in spite of these successes, TB still remains a serious threat, especially for those infected with HIV— the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds sheds light on myths and misconceptions about TB and HIV, and discusses actions needed in preventing deaths from this lethal combination. This is Part 2 of a lecture in three parts. Part 1 &gt;&gt; Part …

Host: Matt Birnholz, MD The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995. But in spite of these successes, TB still remains a serious threat, especially for those infected with HIV— the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB. This special session of Public Health Grand Rounds sheds light on myths and misconceptions about TB and HIV, and discusses actions needed in preventing deaths from this lethal combination. This is Part 2 of a lecture in three parts. <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-1/6390/" rel="nofollow" target="_blank">Part 1 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-3/6392/" rel="nofollow" target="_blank">Part …</a>

CDC - TB & HIV: A Deadly Duo, Part 2


Host: Matt Birnholz, MD  For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss.  In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 1 of a lecture in three parts. Part 2 &gt;&gt; Part 3 &gt;&gt; To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.

Host: Matt Birnholz, MD For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's disease are explored in depth. Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona. This is Part 1 of a lecture in three parts. <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-2/6407/" rel="nofollow" target="_blank">Part 2 &gt;&gt;</a> <a href="/programs/grand-rounds-nation/university-of-arizona-preclinical-stage-alzheimers-disease-characterizing-and-defining-the-transition-between-normal-and-pathological-cognitive-aging-part-3/6408/" rel="nofollow" target="_blank">Part 3 &gt;&gt;</a> To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their <a href="http://streaming.biocom.arizona.edu/categories/?id=50" rel="nofollow" target="_blank">website</a>.

University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1


The best podcast episodes of the most interesting stories and things. From skyping someone while they're in space, to tracking down and meeting a telephone scammer in person, to the story of a Galapagos. These episodes will keep you and all your friends entertained and captivated for hours. Learn something new in every episode! Add episodes you're interested into your queue below!

Best Episodes: Interesting Stories & Things

The best podcast episodes on global issues affecting everyone. Covering topics such as the #metoo movement, climate change, the impact of technology and some of the biggest global issues facing us right now. For anyone interested in learning more about the world, and some of the issues we're facing, pick an episode below and start listening! Add episodes you're interested into your queue below!